Top Markets
Coin of the day
INOVIQ Ltd INOVIQ Ltd

INOVIQ Ltd

IIQ
Rang in aandelen #29959
INOVIQ Ltd specializes in the research, development, and commercialization of... INOVIQ Ltd specializes in the research, development, and commercialization of diagnostic and exosome-based products, aiming to improve the detection and treatment of cancer and other conditions across Australia and the United States. Its current portfolio includes the hTERT test, an immunocytochemistry assay that serves as a supplementary tool for urine cytology in bladder cancer screening, alongside EXO-NET, designed for the capture and isolation of exosomes from liquid biopsy specimens. The company also boasts a robust diagnostic pipeline, featuring blood tests currently under development for various cancers, including ovarian and breast cancer. Originally incorporated in 1983 and formerly known as BARD1 Life Sciences Limited until its rebranding to INOVIQ Ltd in December 2021, the company maintains its headquarters in Notting Hill, Australia.
Aandeelprijs
$0.13400411
Marktkapitalisatie
$18.86M
Verandering (1 dag)
2.70%
Verandering (1 jaar)
-48.10%
Land
AU
Handel INOVIQ Ltd (IIQ)

Categorie

Koersgeschiedenis voor INOVIQ Ltd (IIQ)
Hoogste slotkoers: $0.14 op 2026-08-01

Laagste slotkoers: $166.60 op 1988-01-01
Koersgeschiedenis van INOVIQ Ltd van 1988 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) 1.45%
2025 -30.46%
2024 -24.16%
2023 -0.02%
2022 -43.77%
2021 47.46%
2020 -21.25%
2019 50.59%
2018 181.83%
2017 -75.39%
2016 1.49%
2015 -12.13%
2014 16.04%
2013 -70.72%
2012 -55.14%
2011 -15.17%
2010 21.81%
2009 212.35%
2008 -62.47%
2007 -25.96%
2006 -63.96%
2005 -46.59%
2004 79.49%
2003 90.17%
2002 26.00%
2001 -70.94%
2000 -51.79%
1999 -19.50%
1998 26.20%
1997 -22.09%
1996 77.59%
1995 -11.75%
1994 -13.96%
1993 107.22%
1992 31.18%
1991 187.46%
1990 -83.26%
1989 -66.96%
1988 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$591.22 18.65%
US
$200.34 -5.59%
US
$23.62 87.95%
CN
$312.51 95.17%
US
$557.21 -12.49%
US